Compare Cassava Sciences Inc (FLNA) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs TeraWulf Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while TeraWulf Inc trades at $18.6 (market cap $9.60B). The key difference: TeraWulf Inc is far larger — about 180.7× Cassava Sciences Inc's market cap, and TeraWulf Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | WULF | |
|---|---|---|
Market Cap | $53.14M | $9.60B |
Sector | Health | Technology |
52-Week High | $4.64 | $28.98 |
52-Week Low | $1.09 | $4.76 |
Enterprise Value | -$33.43M | $12.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WULF trades at $18.26, down 5.92% in the last 24 hours, with a bearish technical signal. The company reported a net loss of $661.42 million on $168.46 million revenue in 2025, with negative profitability metrics. However, sentiment is buoyed by a landmark 20-year, $19 billion AI infrastructure deal with Anthropic, positioning TeraWulf in the high-demand data center space. Analyst consensus remains strongly bullish with a $36.00 price target.
The outlook hinges on successful execution of the Anthropic partnership, offering significant revenue potential but requiring substantial capital expenditure. High valuation ratios and persistent losses present risks, yet Wall Street's unanimous buy rating reflects confidence in the AI infrastructure growth story. Investors face volatility from execution risks and sector sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
